Asthma and COPD "overlap": a treatable trait or common several treatable-traits?

J Gaspar Marques1,2, M Lobato1, P Leiria Pinto1,2

  • 1Serviço de Imunoalergologia, Hospital de Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central, E.P.E., Lisboa, Portugal.

Insights

The treatable traits approach offers a framework for managing chronic respiratory diseases (CRD), including asthma-COPD overlap. This review details pulmonary, extra-pulmonary, and lifestyle factors for improved patient outcomes.

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Practice

Background:

  • Recent discussions have focused on classifying chronic respiratory diseases (CRD), introducing concepts like asthma-COPD overlap (ACO).
  • The GOLD consensus (2020) controversially suggested discontinuing the ACO term, viewing asthma and COPD as distinct entities with shared features.
  • The treatable traits approach provides a structured method for managing complex respiratory conditions.

Purpose of the Study:

  • To review the application of the treatable traits approach in chronic respiratory diseases (CRD).
  • To detail identified treatable traits in patients with asthma and COPD.
  • To highlight the clinical relevance of treatable traits for managing CRD.

Main Methods:

  • Literature review focusing on the treatable traits approach in CRD.
  • Identification and categorization of treatable traits in asthma and COPD patients.
  • Analysis of the strengths and applicability of the treatable traits framework.

Main Results:

  • Treatable traits in CRD encompass pulmonary, extra-pulmonary, and behavioral/lifestyle factors.
  • Patients with asthma and COPD exhibit identifiable treatable traits across all categories.
  • Key issues include frequent exacerbations, comorbid cardiovascular disease, and reduced quality of life.

Conclusions:

  • The treatable traits approach is highly applicable to managing CRD, including patients with overlapping asthma and COPD features.
  • Addressing identified treatable traits can potentially mitigate severe exacerbations and improve patient outcomes.
  • Further application of this approach may enhance health-related quality of life and productivity in CRD patients.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
654
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K